Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dare I say that things are looking good here?
Hodling AHFD. Just letting it marinate for now.
Bingo! Lots of stocks across OTC showing the exact same pattern. Load and hold friends.
Changing of the guard.
I’m guessing the market will likely view any addition to the outstanding as bad news, but I do agree with your sentiment. Thanks L&L.
Yup. sleeping giant awakes.
Approaching 1B
The Hearing Assist Walmart deal is gonna be really big for this little company in my opinion.
Nice accumulation going on today.
Mm’s are gonna have people jumping out of windows pretty soon. Max pain coming up. Know what you own people.
Nice to see volume come back here after such great news! Huge deal if they can work it out.
Good call ORCA!
Bring way oversold is a catalyst in and of itself.
“W” formation. Clear for takeoff!
I don’t know. Might just be a couple nervous nellies wanting out. I think we’re due for a good sized bouncy bounce. 911
Bid repopulating again. Tells me most people aren’t fooled by MM tricks. They know what they own. Maybe Koosie is gonna drop an after hours news bomb. Wouldn’t that be great!
Another poor soul lost their shares just now. Warren Buffett was right.
Mm’s definitely know how to put the screws to investors. Sellers will be sorry. They’ll run this back way faster than the slow bleed they’ve been doing for the last 2 months.
Great news!
I think they’ll take it to .0145 before they turn it around.
I guess negotiations with note holders didn’t go so well. Lol
Let’s goooo!!!
Have we reached the stupidly oversold level yet? Lol
Was thinking the same exact thing in regards to the volume.
Ummm…just a wild guess, but maybe for the intellectual property? Let me guess. There’s no value there either, correct? Lol
Getting close now.
Handle almost complete. Time to fill the cup.
Stair steppin’. This next breakout is gonna be a big one. Hodl for the godl.
The game is rigged Art. Believe it. How do you think Peter Thiel turned a $2k retirement account into $5Billion? ….Hmmmm…
Nice job man! Me too. I’ll always take more RGBP at these prices. Dr. Koos is following through on ALL of his promises and bringing shareholder value here.
That data is never accurate anyway as FINRA updates it a month after the fact.
The other thing about the debt is the derivative liability so as the share price rises, that gets erased and that can be quite substantial.
From last 10-Q:
As of September 30,2020 we had Convertible Notes Payable ( Net of Unamortized Interest ) of $2,541,766 and as of June 30, 2021 we had Convertible Notes Payable ( Net of Unamortized Interest )of $2,364,075. The reduction of approximately 6.9% is attributable to conversions of principal indebtedness into the equity securities of the Company offset by amortization of Beneficial Conversion Features recognized on Convertible Indebtedness.
Material Changes in Results of Operations
Revenues from continuing operations were $1,932,425 for the quarter ended June 30,2021 and $27,425 for the same period ended 2020. The increase of approximately 6, 946% is attributable to $1,905,000 of revenue recognized during the quarter ended June 30, 2021 pursuant to a license granted to Oncology Pharma,Inc. Operating Income was $1,833,303 for the quarter ended June 30,2021 whereas Operating Loss was $16,336 for the same quarter ended 2020; an increase primarily attributable to $1,905,000 of revenue recognized during the quarter ended June 30,2021 pursuant to a license granted to Oncology Pharma,Inc
Net Loss was $ 5,613,321 for the quarter ended June 30, 2021 versus Net Income of $3,205,945 recognized during the same period ended 2020. This was primarily attributable to a Derivative Loss recognized during the quarter ended June 30, 2021.
Revenues from continuing operations were $1,987,274 for the nine months ended June 30,2021 and $82,274 for the same period ended 2020. The increase of approximately 2,315% is attributable to $1,905,000 of revenue recognized during the quarter ended June 30, 2021 pursuant to a license granted to Oncology Pharma,Inc. Operating Income was $1,801,849 for the nine months ended June 30,2021 whereas Operating Loss was $190,408 for the same nine months ended 2020; an increase primarily attributable to $1,905,000 of revenue recognized during the quarter ended June 30,2021 pursuant to a license granted to Oncology Pharma, Inc.
63
Net Loss was $3,504,772 for the nine months ended June 30, 2021 versus Net Income of $2,211,567 recognized during the same period ended 2020. This was primarily attributable to a Derivative Loss recognized during the quarter ended June 30, 2021.
As of June 30, 2021 we had $188,179 in cash on hand and current liabilities of $11,969,547 such liabilities consisting of Accounts Payable, Notes Payable, Convertible Notes Payable , Derivative Liability Recognized, bank overdraft and Accrued Expenses. We feel we will not be able to satisfy our cash requirements over the next twelve months and shall be required to seek additional financing.
As of June 30, 2021 the Company was not party to any binding agreements which would commit Regen to any material capital expenditures.
Amazing!!! This is the piece I’ve been waiting for! Toxic notes screw the shareholders so bad and just like that, now they’re gone. Poof.
Looking good. Congrats to the patient people who are getting these.
I know, but one can always hope foolish souls will panic sell with a momentary lapse of reason. Got my orders in. Ready and waiting.
Hopefully they drop this sub penny. That would be awesome! C’mon mm’s. I believe in you! Let’s drive this thing down!
Thanks for the cheapies.
I own shares here, but just wanted to inquire as to why, besides share structure, are people holding these preferred shares as opposed to common shares.